|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects localization |
ISO |
alpinumisoflavone affects the localization of BAX protein |
CTD |
PMID:23850732 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
alpinumisoflavone results in decreased expression of BCL2 protein |
CTD |
PMID:23850732 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression |
ISO |
alpinumisoflavone results in decreased expression of BID protein |
CTD |
PMID:23850732 |
|
NCBI chr 4:153,439,812...153,465,247
Ensembl chr 4:153,442,218...153,465,203
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage |
ISO |
[alpinumisoflavone results in increased expression of FAS protein] which results in increased cleavage of CASP3 protein alpinumisoflavone results in increased cleavage of CASP3 protein |
CTD |
PMID:23850732 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions |
ISO |
alpinumisoflavone results in increased cleavage of CASP9 protein [alpinumisoflavone results in increased expression of FAS protein] which results in increased cleavage of CASP9 protein |
CTD |
PMID:23850732 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
decreases expression |
ISO |
alpinumisoflavone results in decreased expression of CHUK protein |
CTD |
PMID:23850732 |
|
NCBI chr 1:263,848,829...263,884,354
Ensembl chr 1:263,848,884...263,885,169
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization |
ISO |
alpinumisoflavone affects the localization of CYCS protein |
CTD |
PMID:23850732 |
|
NCBI chr 4:80,331,226...80,333,326
Ensembl chr 4:80,331,227...80,333,326
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions increases expression |
ISO |
[alpinumisoflavone results in increased expression of FAS protein] which results in increased cleavage of CASP3 protein; [alpinumisoflavone results in increased expression of FAS protein] which results in increased cleavage of CASP9 protein |
CTD |
PMID:23850732 |
|
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
alpinumisoflavone inhibits the reaction [1,10-phenanthroline deficiency results in increased activity of HIF1A protein]; alpinumisoflavone inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein] |
CTD |
PMID:19091749 |
|
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
alpinumisoflavone results in increased cleavage of PARP1 protein |
CTD |
PMID:23850732 |
|
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
decreases expression |
ISO |
alpinumisoflavone results in decreased expression of RELA protein |
CTD |
PMID:23850732 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
alpinumisoflavone results in decreased phosphorylation of and results in decreased activity of STAT3 protein |
CTD |
PMID:23850732 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
multiple interactions |
ISO |
alpinumisoflavone results in decreased phosphorylation of and results in decreased activity of STAT5A protein |
CTD |
PMID:23850732 |
|
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
multiple interactions |
ISO |
alpinumisoflavone results in decreased phosphorylation of and results in decreased activity of STAT6 protein |
CTD |
PMID:23850732 |
|
NCBI chr 7:70,946,228...70,963,542
Ensembl chr 7:70,946,228...70,964,484
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
[[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein; [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein; [[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein |
CTD |
PMID:20638373 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
cajanol results in decreased expression of BCL2 protein [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein; [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein; [[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein |
CTD |
PMID:20638373 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
[[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein cajanol results in increased activity of CASP3 protein |
CTD |
PMID:20638373 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity |
ISO |
[[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein cajanol results in increased activity of CASP9 protein |
CTD |
PMID:20638373 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization multiple interactions |
ISO |
cajanol affects the localization of CYCS protein [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein; [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein; [[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein |
CTD |
PMID:20638373 |
|
NCBI chr 4:80,331,226...80,333,326
Ensembl chr 4:80,331,227...80,333,326
|
|
|
G |
Adm |
adrenomedullin |
multiple interactions |
ISO |
deguelin inhibits the reaction [Oxygen deficiency results in increased expression of ADM mRNA] |
CTD |
PMID:22745725 |
|
NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions |
ISO |
deguelin results in increased expression of and affects the localization of AIFM1 protein |
CTD |
PMID:26592500 |
|
NCBI chr X:135,304,063...135,343,062
Ensembl chr X:135,304,066...135,343,087
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression affects phosphorylation increases phosphorylation multiple interactions decreases phosphorylation |
ISO |
deguelin metabolite results in decreased expression of AKT1 protein; deguelin results in decreased expression of AKT1 protein deguelin affects the phosphorylation of AKT1 protein deguelin results in increased phosphorylation of AKT1 protein deguelin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of AKT1 protein] deguelin results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:16288123 PMID:17015749 PMID:18593368 PMID:19139008 PMID:19336726 PMID:19901985 PMID:25322282 PMID:29512685 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Angptl4 |
angiopoietin-like 4 |
multiple interactions |
ISO |
deguelin inhibits the reaction [Oxygen deficiency results in increased expression of ANGPTL4 mRNA] |
CTD |
PMID:22745725 |
|
NCBI chr 7:18,627,814...18,634,043
Ensembl chr 7:18,627,808...18,634,079
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
deguelin results in decreased expression of and affects the localization of AR protein |
CTD |
PMID:27255535 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases expression |
ISO |
deguelin results in decreased expression of ATM mRNA |
CTD |
PMID:22227970 |
|
NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
|
|
G |
Atr |
ATR serine/threonine kinase |
decreases expression |
ISO |
deguelin results in decreased expression of ATR mRNA |
CTD |
PMID:22227970 |
|
NCBI chr 8:103,673,578...103,770,886
Ensembl chr 8:103,673,411...103,770,947
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
deguelin results in increased expression of BAK1 protein |
CTD |
PMID:26592500 |
|
NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
deguelin results in increased expression of BAX mRNA; deguelin results in increased expression of BAX protein |
CTD |
PMID:26592500 PMID:29512685 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
deguelin results in decreased expression of BCL2 mRNA; deguelin results in decreased expression of BCL2 protein deguelin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] |
CTD |
PMID:19365708 PMID:22623043 PMID:26592500 PMID:29512685 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions decreases expression |
ISO |
deguelin inhibits the reaction [TNF protein results in increased expression of BCL2L1 mRNA] deguelin results in decreased expression of BCL2L1 mRNA; deguelin results in decreased expression of BCL2L1 protein |
CTD |
PMID:19365708 PMID:21472727 PMID:22623043 PMID:26592500 |
|
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
deguelin inhibits the reaction [BDNF protein results in increased expression of PPP1R1B protein] |
CTD |
PMID:17209049 |
|
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions decreases expression |
ISO |
deguelin inhibits the reaction [docetaxel results in increased expression of BIRC5 protein]; deguelin inhibits the reaction [Doxorubicin results in increased expression of BIRC5 protein] deguelin results in decreased expression of BIRC5 protein |
CTD |
PMID:17035597 PMID:18593368 PMID:21472727 |
|
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
deguelin results in decreased expression of BRCA1 mRNA |
CTD |
PMID:22227970 |
|
NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
|
|
G |
Ca9 |
carbonic anhydrase 9 |
multiple interactions |
ISO |
deguelin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] |
CTD |
PMID:22745725 |
|
NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions increases activity |
ISO |
deguelin results in increased cleavage of CASP3 protein [NPM1 protein mutant form results in increased susceptibility to deguelin] which results in increased cleavage of CASP3 protein deguelin results in increased activity of CASP3 protein |
CTD |
PMID:18593368 PMID:19336726 PMID:22623043 PMID:22986522 PMID:25242579 PMID:26592500 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp6 |
caspase 6 |
multiple interactions |
ISO |
[NPM1 protein mutant form results in increased susceptibility to deguelin] which results in decreased expression of and results in increased activity of CASP6 protein |
CTD |
PMID:25242579 |
|
NCBI chr 2:235,341,326...235,353,715
Ensembl chr 2:235,341,365...235,353,967 Ensembl chr 2:235,341,365...235,353,967
|
|
G |
Casp7 |
caspase 7 |
increases expression |
ISO |
deguelin metabolite results in increased expression of CASP7 protein modified form; deguelin results in increased expression of CASP7 protein modified form |
CTD |
PMID:19139008 |
|
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
[NPM1 protein mutant form results in increased susceptibility to deguelin] which results in decreased expression of and results in increased activity of CASP8 protein |
CTD |
PMID:25242579 |
|
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
deguelin promotes the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] |
CTD |
PMID:22745725 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
deguelin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] |
CTD |
PMID:28529457 |
|
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO |
[deguelin results in increased degradation of CTNNB1 protein] which results in decreased expression of CCND1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [deguelin results in decreased expression of CCND1 protein]; deguelin inhibits the reaction [TNF protein results in increased expression of CCND1 protein] |
CTD |
PMID:15960896 PMID:17015749 PMID:19861542 PMID:21472727 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
ISO |
deguelin results in decreased expression of CCNE1 mRNA |
CTD |
PMID:29512685 |
|
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Cd14 |
CD14 molecule |
multiple interactions |
ISO |
[NPM1 protein mutant form results in increased susceptibility to deguelin] which results in increased expression of CD14 protein |
CTD |
PMID:25242579 |
|
NCBI chr18:29,560,341...29,562,290
Ensembl chr18:29,560,365...29,562,153
|
|
G |
Cd163 |
CD163 molecule |
multiple interactions |
EXP |
[deguelin co-treated with Oxygen deficiency] results in increased expression of CD163 mRNA |
CTD |
PMID:22745725 |
|
NCBI chr 4:156,752,063...156,785,467
Ensembl chr 4:156,752,082...156,785,467
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
decreases expression |
ISO |
deguelin results in decreased expression of CD44 mRNA; deguelin results in decreased expression of CD44 protein |
CTD |
PMID:26884827 |
|
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions affects localization increases expression |
ISO |
deguelin inhibits the reaction [TGFB1 protein results in increased expression of CDH1 protein]; deguelin promotes the reaction [CTNNB1 protein binds to CDH1 protein] deguelin affects the localization of CDH1 protein deguelin results in increased expression of CDH1 mRNA; deguelin results in increased expression of CDH1 protein |
CTD |
PMID:22986522 PMID:28509438 |
|
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression |
ISO |
deguelin results in decreased expression of CDH2 protein |
CTD |
PMID:22986522 |
|
NCBI chr18:8,146,971...8,366,037
Ensembl chr18:8,146,971...8,360,684
|
|
G |
Cdh3 |
cadherin 3 |
increases expression |
ISO |
deguelin results in increased expression of CDH3 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr19:38,668,957...38,719,801
Ensembl chr19:38,669,230...38,719,677
|
|
G |
Cdh7 |
cadherin 7 |
increases expression |
ISO |
deguelin results in increased expression of CDH7 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr13:31,081,064...31,228,884
Ensembl chr13:31,081,804...31,231,213
|
|
G |
Cdh9 |
cadherin 9 |
increases expression |
ISO |
deguelin results in increased expression of CDH9 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 2:66,938,796...67,078,897
Ensembl chr 2:66,940,057...67,078,784
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
deguelin metabolite results in decreased expression of CDK4 protein; deguelin results in decreased expression of CDK4 protein |
CTD |
PMID:19139008 PMID:19336726 |
|
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression increases expression |
ISO |
[deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of CDKN1A protein; deguelin metabolite results in decreased expression of CDKN1A protein; deguelin results in decreased expression of CDKN1A protein deguelin results in increased expression of CDKN1A mRNA |
CTD |
PMID:19139008 PMID:25242579 PMID:29512685 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression |
ISO |
[deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of CEBPA protein |
CTD |
PMID:25242579 |
|
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions decreases expression |
ISO |
deguelin inhibits the reaction [TNF protein results in increased expression of CFLAR mRNA] deguelin results in decreased expression of CFLAR mRNA |
CTD |
PMID:22623043 |
|
NCBI chr 9:65,534,608...65,586,395
Ensembl chr 9:65,534,704...65,587,251
|
|
G |
Cldn2 |
claudin 2 |
increases expression |
ISO |
deguelin results in increased expression of CLDN2 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr X:111,122,552...111,133,188
Ensembl chr X:111,122,552...111,137,769
|
|
G |
Cldn5 |
claudin 5 |
increases expression |
ISO |
deguelin results in increased expression of CLDN5 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr11:86,356,292...86,357,718
Ensembl chr11:86,356,294...86,357,718
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression increases degradation |
ISO |
[deguelin results in increased degradation of CTNNB1 protein] which results in decreased expression of CCND1 protein; [deguelin results in increased degradation of CTNNB1 protein] which results in decreased expression of MYC protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [deguelin results in decreased expression of CTNNB1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [deguelin results in increased degradation of CTNNB1 protein]; deguelin promotes the reaction [CTNNB1 protein binds to CDH1 protein] |
CTD |
PMID:21472727 PMID:22986522 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
multiple interactions |
ISO |
deguelin inhibits the reaction [Oxygen deficiency results in increased expression of CXCR4 mRNA] |
CTD |
PMID:22745725 |
|
NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
deguelin inhibits the reaction [1-nitropyrene results in increased stability of CYP1A1 mRNA] |
CTD |
PMID:19961161 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Dkk2 |
dickkopf WNT signaling pathway inhibitor 2 |
decreases expression |
ISO |
deguelin results in decreased expression of DKK2 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 2:237,148,918...237,240,883
Ensembl chr 2:237,148,941...237,241,350
|
|
G |
Dkk4 |
dickkopf WNT signaling pathway inhibitor 4 |
increases expression |
ISO |
deguelin results in increased expression of DKK4 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr16:74,260,551...74,264,142
Ensembl chr16:74,260,551...74,264,142
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
ISO |
deguelin metabolite results in decreased expression of EGFR protein; deguelin results in decreased expression of EGFR protein |
CTD |
PMID:19139008 |
|
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
multiple interactions |
ISO |
deguelin inhibits the reaction [Oxygen deficiency results in increased expression of EGLN3 mRNA] |
CTD |
PMID:22745725 |
|
NCBI chr 6:75,050,329...75,075,795
Ensembl chr 6:75,050,329...75,075,795
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases phosphorylation |
ISO |
deguelin results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:25322282 |
|
NCBI chr 4:98,648,513...98,709,695
Ensembl chr 4:98,648,545...98,709,694
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
decreases expression decreases phosphorylation |
ISO |
deguelin metabolite results in decreased expression of EIF4EBP1 protein modified form; deguelin results in decreased expression of EIF4EBP1 protein modified form deguelin results in decreased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:19139008 PMID:27255535 |
|
NCBI chr16:68,954,860...68,968,248
Ensembl chr16:68,954,875...68,968,248
|
|
G |
Eno2 |
enolase 2 |
decreases secretion |
ISO |
deguelin results in decreased secretion of ENO2 protein |
CTD |
PMID:26884827 |
|
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
multiple interactions |
ISO |
deguelin inhibits the reaction [Oxygen deficiency results in increased expression of ENTPD1 protein] |
CTD |
PMID:27899277 |
|
NCBI chr 1:259,692,020...259,818,922
Ensembl chr 1:259,739,955...259,819,494
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
decreases expression |
ISO |
deguelin results in decreased expression of EPAS1 protein |
CTD |
PMID:19336726 |
|
NCBI chr 6:10,306,508...10,385,239
Ensembl chr 6:10,306,405...10,387,265
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
decreases expression |
ISO |
deguelin results in decreased expression of ERN1 protein |
CTD |
PMID:25322282 |
|
NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
deguelin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS mRNA] |
CTD |
PMID:9270009 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Frzb |
frizzled-related protein |
increases expression |
ISO |
deguelin results in increased expression of FRZB mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 3:67,635,604...67,668,772
Ensembl chr 3:67,635,607...67,668,772
|
|
G |
Fzd10 |
frizzled class receptor 10 |
increases expression |
ISO |
deguelin results in increased expression of FZD10 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr12:31,757,407...31,760,604
Ensembl chr12:31,757,407...31,760,604
|
|
G |
Fzd4 |
frizzled class receptor 4 |
increases expression |
ISO |
deguelin results in increased expression of FZD4 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 1:153,589,471...153,598,376
Ensembl chr 1:153,589,471...153,598,375
|
|
G |
Fzd8 |
frizzled class receptor 8 |
increases expression |
ISO |
deguelin results in increased expression of FZD8 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr17:62,259,910...62,267,239
Ensembl chr17:62,262,129...62,265,113
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases phosphorylation |
ISO |
deguelin results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:19336726 PMID:21472727 |
|
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases degradation multiple interactions |
ISO |
deguelin results in increased degradation of HIF1A protein benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [deguelin results in increased degradation of HIF1A protein]; deguelin inhibits the reaction [IGF1 protein results in increased expression of HIF1A protein]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; deguelin metabolite inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] |
CTD |
PMID:17764071 PMID:18575727 PMID:19139008 PMID:22745725 PMID:27899277 |
|
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
deguelin inhibits the reaction [Oxygen deficiency results in increased expression of ICAM1 mRNA]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of ICAM1 protein]; deguelin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:17015749 PMID:22745725 |
|
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP ISO |
deguelin inhibits the reaction [Perfadex results in increased expression of IFNG protein] [deguelin co-treated with OVAL protein] results in increased expression of IFNG protein |
CTD |
PMID:22745725 PMID:28529457 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
deguelin inhibits the reaction [IGF1 protein results in increased expression of HIF1A protein]; deguelin inhibits the reaction [IGF1 protein results in increased expression of VEGFA mRNA] |
CTD |
PMID:17764071 |
|
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
decreases expression |
ISO |
deguelin metabolite results in decreased expression of IGF1R protein; deguelin results in decreased expression of IGF1R protein |
CTD |
PMID:19139008 |
|
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
increases expression |
ISO |
deguelin results in increased expression of IHH mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 9:82,208,223...82,214,440
Ensembl chr 9:82,208,223...82,214,440
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
deguelin inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA] |
CTD |
PMID:22745725 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
deguelin inhibits the reaction [OVAL protein results in increased expression of IL13 protein] |
CTD |
PMID:28529457 |
|
NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
EXP ISO |
deguelin inhibits the reaction [Oxygen deficiency results in decreased expression of IL4 mRNA] deguelin inhibits the reaction [OVAL protein results in increased expression of IL4 mRNA]; deguelin inhibits the reaction [OVAL protein results in increased expression of IL4 protein] |
CTD |
PMID:22745725 PMID:28529457 |
|
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
deguelin inhibits the reaction [OVAL protein results in increased expression of IL5 protein] |
CTD |
PMID:28529457 |
|
NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
deguelin inhibits the reaction [Perfadex results in decreased expression of IL6 protein] |
CTD |
PMID:22745725 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
[NPM1 protein mutant form results in increased susceptibility to deguelin] which results in increased expression of ITGAM protein |
CTD |
PMID:25242579 |
|
NCBI chr 1:199,495,312...199,545,738
Ensembl chr 1:199,495,298...199,623,960
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases phosphorylation |
ISO |
deguelin results in increased phosphorylation of JUN protein |
CTD |
PMID:25322282 |
|
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Kdr |
kinase insert domain receptor |
decreases expression |
ISO |
deguelin metabolite results in decreased expression of KDR protein; deguelin results in decreased expression of KDR protein |
CTD |
PMID:19139008 |
|
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
|
|
G |
Krt18 |
keratin 18 |
increases expression multiple interactions |
ISO |
deguelin results in increased expression of KRT18 protein deguelin inhibits the reaction [TGFB1 protein results in decreased expression of KRT18 protein] |
CTD |
PMID:22986522 |
|
NCBI chr 7:143,629,455...143,633,131
Ensembl chr 7:143,629,455...143,633,131
|
|
G |
Lox |
lysyl oxidase |
multiple interactions |
ISO |
deguelin inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA] |
CTD |
PMID:22745725 |
|
NCBI chr18:47,500,320...47,577,819
Ensembl chr18:47,500,330...47,577,819
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
decreases expression |
ISO |
deguelin metabolite results in decreased expression of MAP2K1 protein; deguelin results in decreased expression of MAP2K1 protein |
CTD |
PMID:19139008 PMID:19336726 |
|
NCBI chr 8:69,134,218...69,722,573
Ensembl chr 8:69,134,223...69,164,758
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
decreases expression |
ISO |
deguelin results in decreased expression of MAP2K2 protein |
CTD |
PMID:19336726 |
|
NCBI chr 7:11,458,971...11,478,520
Ensembl chr 7:11,458,967...11,478,489
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
decreases expression |
ISO |
deguelin results in decreased expression of MAP2K7 protein |
CTD |
PMID:25322282 |
|
NCBI chr12:2,546,278...2,555,310
Ensembl chr12:2,548,218...2,555,164
|
|
G |
Map3k3 |
mitogen activated protein kinase kinase kinase 3 |
affects expression |
ISO |
deguelin affects the expression of MAP3K3 protein |
CTD |
PMID:25322282 |
|
NCBI chr10:94,280,703...94,349,372
Ensembl chr10:94,280,703...94,349,368
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
affects phosphorylation |
ISO |
deguelin affects the phosphorylation of MAPK1 protein |
CTD |
PMID:25322282 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
affects phosphorylation |
ISO |
deguelin affects the phosphorylation of MAPK3 protein |
CTD |
PMID:25322282 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression |
ISO |
deguelin results in decreased expression of MCL1 protein |
CTD |
PMID:21472727 |
|
NCBI chr 2:197,786,212...197,788,992
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
decreases expression |
ISO |
deguelin results in decreased expression of MGMT mRNA |
CTD |
PMID:22227970 |
|
NCBI chr 1:209,237,255...209,464,189
Ensembl chr 1:209,237,233...209,464,190
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
deguelin results in decreased expression of MKI67 protein |
CTD |
PMID:22623043 |
|
NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
decreases expression |
ISO |
deguelin results in decreased expression of MMP1 protein |
CTD |
PMID:25322282 |
|
NCBI chr 8:5,703,206...5,723,593
Ensembl chr 8:5,703,206...5,723,591
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
decreases expression |
ISO |
deguelin results in decreased expression of MMP13 protein |
CTD |
PMID:25322282 |
|
NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
ISO |
deguelin results in decreased expression of and results in decreased activity of MMP2 protein deguelin results in decreased expression of MMP2 mRNA; deguelin results in decreased expression of MMP2 protein |
CTD |
PMID:25322282 PMID:26884827 |
|
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
ISO |
deguelin results in decreased expression of MMP7 mRNA |
CTD |
PMID:25322282 |
|
NCBI chr 8:5,893,253...5,900,965
Ensembl chr 8:5,893,249...5,901,049
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression decreases activity |
ISO |
deguelin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] deguelin results in decreased expression of MMP9 mRNA; deguelin results in decreased expression of MMP9 protein deguelin results in decreased activity of MMP9 protein |
CTD |
PMID:17015749 PMID:25322282 PMID:26884827 |
|
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
multiple interactions |
EXP |
deguelin promotes the reaction [Oxygen deficiency results in increased expression of MRC1 mRNA] |
CTD |
PMID:22745725 |
|
NCBI chr17:81,352,700...81,433,743
Ensembl chr17:81,352,700...81,433,743
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases expression decreases phosphorylation |
ISO |
deguelin metabolite results in decreased expression of MTOR protein; deguelin results in decreased expression of MTOR protein deguelin results in decreased phosphorylation of MTOR protein |
CTD |
PMID:19139008 PMID:27255535 |
|
NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
deguelin inhibits the reaction [OVAL protein results in increased expression of MUC5AC mRNA] |
CTD |
PMID:28529457 |
|
NCBI chr 1:214,725,482...214,756,653
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions decreases expression |
ISO |
[deguelin results in increased degradation of CTNNB1 protein] which results in decreased expression of MYC protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [deguelin results in decreased expression of MYC protein]; deguelin inhibits the reaction [TNF protein results in increased expression of MYC protein] deguelin inhibits the reaction [MYC protein results in increased activity of ODC1 protein] |
CTD |
PMID:9270009 PMID:17015749 PMID:21472727 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Ncoa3 |
nuclear receptor coactivator 3 |
decreases expression |
ISO |
deguelin results in decreased expression of NCOA3 mRNA; deguelin results in decreased expression of NCOA3 protein |
CTD |
PMID:19365708 |
|
NCBI chr 3:162,692,176...162,788,582
Ensembl chr 3:162,692,185...162,787,548
|
|
G |
Nek2 |
NIMA-related kinase 2 |
decreases expression |
ISO |
deguelin results in decreased expression of NEK2 mRNA; deguelin results in decreased expression of NEK2 protein |
CTD |
PMID:28509438 |
|
NCBI chr13:110,511,546...110,524,750
Ensembl chr13:110,511,668...110,522,769
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
deguelin inhibits the reaction [TNF protein results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; deguelin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] deguelin inhibits the reaction [OVAL protein results in increased degradation of and results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:17015749 PMID:22623043 PMID:28529457 |
|
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression multiple interactions |
ISO |
deguelin results in decreased expression of NOS2 protein deguelin inhibits the reaction [OVAL protein results in increased expression of NOS2 mRNA] |
CTD |
PMID:25322282 PMID:28529457 |
|
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Nos3 |
nitric oxide synthase 3 |
decreases expression |
ISO |
deguelin results in decreased expression of NOS3 protein |
CTD |
PMID:19336726 |
|
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Npm1 |
nucleophosmin 1 |
decreases expression multiple interactions increases response to substance |
ISO |
[deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of CDKN1A protein; [deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of CEBPA protein; [deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of TP53 protein [NPM1 protein mutant form results in increased susceptibility to deguelin] which results in decreased expression of and results in increased activity of CASP6 protein; [NPM1 protein mutant form results in increased susceptibility to deguelin] which results in decreased expression of and results in increased activity of CASP8 protein; [NPM1 protein mutant form results in increased susceptibility to deguelin] which results in increased cleavage of CASP3 protein; [NPM1 protein mutant form results in increased susceptibility to deguelin] which results in increased cleavage of PARP1 protein; [NPM1 protein mutant form results in increased susceptibility to deguelin] which results in increased expression of CD14 protein; [NPM1 protein mutant form results in increased susceptibility to deguelin] which results in increased expression of ITGAM protein |
CTD |
PMID:25242579 |
|
NCBI chr10:18,080,949...18,091,062
Ensembl chr10:18,080,950...18,090,950
|
|
G |
Nt5e |
5' nucleotidase, ecto |
multiple interactions |
ISO |
deguelin inhibits the reaction [Oxygen deficiency results in increased expression of NT5E protein] |
CTD |
PMID:27899277 |
|
NCBI chr 8:95,969,002...96,012,733
Ensembl chr 8:95,968,652...96,012,696
|
|
G |
Nup98 |
nucleoporin 98 and 96 precursor |
decreases expression |
ISO |
deguelin results in decreased expression of NUP98 mRNA; deguelin results in decreased expression of NUP98 protein |
CTD |
PMID:17490514 |
|
NCBI chr 1:167,213,866...167,308,851
Ensembl chr 1:167,213,866...167,308,851
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
increases activity multiple interactions |
ISO |
deguelin results in increased activity of ODC1 protein deguelin inhibits the reaction [MYC protein results in increased activity of ODC1 protein]; deguelin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ODC1 mRNA] |
CTD |
PMID:9270009 PMID:9834970 |
|
NCBI chr 6:42,852,529...42,859,142
Ensembl chr 6:42,852,683...42,859,927
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage increases expression |
ISO |
[NPM1 protein mutant form results in increased susceptibility to deguelin] which results in increased cleavage of PARP1 protein; deguelin inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein] deguelin results in increased cleavage of PARP1 protein deguelin metabolite results in increased expression of PARP1 protein modified form; deguelin results in increased expression of PARP1 protein modified form |
CTD |
PMID:17015749 PMID:17035597 PMID:19139008 PMID:22986522 PMID:25242579 |
|
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
decreases expression |
ISO |
deguelin metabolite results in decreased expression of PDK1 protein; deguelin results in decreased expression of PDK1 protein |
CTD |
PMID:19139008 |
|
NCBI chr 3:58,530,870...58,561,494
Ensembl chr 3:58,530,870...58,558,027
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
decreases expression |
ISO |
deguelin metabolite results in decreased expression of PIK3CA protein; deguelin results in decreased expression of PIK3CA protein |
CTD |
PMID:19139008 |
|
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
increases phosphorylation |
ISO |
deguelin results in increased phosphorylation of PLCG1 protein |
CTD |
PMID:19901985 |
|
NCBI chr 3:156,727,642...156,758,307
Ensembl chr 3:156,727,642...156,758,307
|
|
G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
multiple interactions |
ISO |
deguelin inhibits the reaction [BDNF protein results in increased expression of PPP1R1B protein] |
CTD |
PMID:17209049 |
|
NCBI chr10:86,303,727...86,312,770
Ensembl chr10:86,303,727...86,312,762
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
increases phosphorylation |
ISO |
deguelin results in increased phosphorylation of PRKAA1 protein |
CTD |
PMID:19901985 |
|
NCBI chr 2:54,857,688...54,893,404
Ensembl chr 2:54,857,688...54,893,404
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
decreases expression |
ISO |
deguelin results in decreased expression of PRKDC mRNA |
CTD |
PMID:22227970 |
|
NCBI chr11:89,293,547...89,510,948
Ensembl chr11:89,293,696...89,510,871
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression |
ISO |
deguelin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] deguelin results in decreased expression of PTGS2 protein |
CTD |
PMID:17015749 PMID:25322282 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases expression |
ISO |
deguelin results in decreased expression of PTK2 protein |
CTD |
PMID:25322282 |
|
NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
|
|
G |
Rac1 |
Rac family small GTPase 1 |
decreases expression |
ISO |
deguelin results in decreased expression of RAC1 protein |
CTD |
PMID:26884827 |
|
NCBI chr12:13,090,316...13,111,841
Ensembl chr12:13,090,172...13,111,873
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
deguelin results in decreased expression of RB1 protein |
CTD |
PMID:15960896 |
|
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
decreases expression multiple interactions decreases phosphorylation |
ISO |
deguelin results in decreased expression of RELA mRNA; deguelin results in decreased expression of RELA protein deguelin inhibits the reaction [OVAL protein affects the localization of and results in increased phosphorylation of RELA protein] deguelin results in decreased phosphorylation of RELA protein deguelin inhibits the reaction [TNF protein affects the localization of and results in increased phosphorylation of RELA protein]; deguelin inhibits the reaction [TNF protein results in increased phosphorylation of and affects the localization of RELA protein] |
CTD |
PMID:17015749 PMID:19365708 PMID:22623043 PMID:28529457 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Rhoa |
ras homolog family member A |
decreases expression |
ISO |
deguelin results in decreased expression of RHOA mRNA; deguelin results in decreased expression of RHOA protein |
CTD |
PMID:25322282 |
|
NCBI chr 8:117,082,440...117,116,244
Ensembl chr 8:117,106,576...117,116,167
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
decreases expression |
ISO |
deguelin results in decreased expression of ROCK1 protein |
CTD |
PMID:25322282 PMID:26884827 |
|
NCBI chr18:1,273,490...1,390,790
Ensembl chr18:1,273,453...1,390,190
|
|
G |
Rps6 |
ribosomal protein S6 |
decreases expression decreases phosphorylation |
ISO |
deguelin metabolite results in decreased expression of RPS6 protein; deguelin metabolite results in decreased expression of RPS6 protein modified form; deguelin results in decreased expression of RPS6 protein; deguelin results in decreased expression of RPS6 protein modified form deguelin results in decreased phosphorylation of RPS6 protein |
CTD |
PMID:19139008 PMID:27255535 |
|
NCBI chr 5:105,197,821...105,200,681
Ensembl chr 5:105,197,857...105,200,148
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
decreases expression decreases phosphorylation |
ISO |
deguelin metabolite results in decreased expression of RPS6KB1 protein; deguelin results in decreased expression of RPS6KB1 protein deguelin results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:19139008 PMID:27255535 |
|
NCBI chr10:73,824,200...73,865,503
Ensembl chr10:73,824,202...73,865,364
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
deguelin inhibits the reaction [TNF protein results in increased expression of SELE mRNA] deguelin inhibits the reaction [OVAL protein results in increased expression of SELE mRNA] |
CTD |
PMID:28529457 |
|
NCBI chr13:82,355,234...82,365,323
Ensembl chr13:82,355,471...82,365,341
|
|
G |
Serpinb3 |
serpin family B member 3 |
decreases secretion |
ISO |
deguelin results in decreased secretion of SERPINB3 protein |
CTD |
PMID:26884827 |
|
NCBI chr13:27,186,701...27,193,211
Ensembl chr13:27,187,130...27,192,592
|
|
G |
Sfrp2 |
secreted frizzled-related protein 2 |
decreases expression |
ISO |
deguelin results in decreased expression of SFRP2 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 2:182,723,732...182,731,277
Ensembl chr 2:182,723,854...182,731,764
|
|
G |
Smad3 |
SMAD family member 3 |
decreases phosphorylation |
ISO |
deguelin results in decreased phosphorylation of SMAD3 protein |
CTD |
PMID:22986522 |
|
NCBI chr 8:68,569,530...68,678,349
Ensembl chr 8:68,569,530...68,678,349
|
|
G |
Smad4 |
SMAD family member 4 |
multiple interactions |
ISO |
deguelin inhibits the reaction [TGFB1 protein affects the localization of SMAD4 protein] |
CTD |
PMID:22986522 |
|
NCBI chr18:69,626,682...69,657,373
Ensembl chr18:69,627,757...69,671,199
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
decreases expression multiple interactions |
ISO |
deguelin results in decreased expression of SNAI1 mRNA; deguelin results in decreased expression of SNAI1 protein deguelin inhibits the reaction [TGFB1 protein results in increased expression of SNAI1 protein] |
CTD |
PMID:19861542 PMID:22986522 |
|
NCBI chr 3:164,274,710...164,279,199
Ensembl chr 3:164,274,710...164,279,378
|
|
G |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
deguelin results in decreased expression of SOS1 protein |
CTD |
PMID:25322282 |
|
NCBI chr 6:3,105,443...3,182,977
Ensembl chr 6:3,104,861...3,182,996
|
|
G |
Sox14 |
SRY-box transcription factor 14 |
increases expression |
ISO |
deguelin results in increased expression of SOX14 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 8:108,107,865...108,109,801
Ensembl chr 8:108,107,865...108,109,801
|
|
G |
Sox30 |
SRY-box transcription factor 30 |
increases expression |
ISO |
deguelin results in increased expression of SOX30 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr10:31,074,251...31,102,211
Ensembl chr10:31,074,251...31,102,169
|
|
G |
Sox5 |
SRY-box transcription factor 5 |
increases expression |
ISO |
deguelin results in increased expression of SOX5 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 4:178,062,267...179,031,991
Ensembl chr 4:178,066,165...178,441,547
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases activity |
ISO |
deguelin metabolite results in increased activity of SRC protein; deguelin results in increased activity of SRC protein |
CTD |
PMID:19139008 |
|
NCBI chr 3:153,547,807...153,595,643
Ensembl chr 3:153,580,861...153,595,642
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases activity |
ISO |
deguelin metabolite results in increased activity of STAT3 protein; deguelin results in increased activity of STAT3 protein |
CTD |
PMID:19139008 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
increases phosphorylation |
ISO |
deguelin metabolite results in increased phosphorylation of STAT6 protein; deguelin results in increased phosphorylation of STAT6 protein |
CTD |
PMID:19139008 |
|
NCBI chr 7:70,946,228...70,963,542
Ensembl chr 7:70,946,228...70,964,484
|
|
G |
Sts |
steroid sulfatase |
multiple interactions |
ISO |
deguelin inhibits the reaction [Tretinoin results in increased activity of STS protein] |
CTD |
PMID:16178010 |
|
NCBI chr X:45,420,418...45,428,748
Ensembl chr X:45,420,596...45,428,750
|
|
G |
Tcf4 |
transcription factor 4 |
increases expression |
ISO |
deguelin results in increased expression of TCF4 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr18:65,285,320...65,507,983
Ensembl chr18:65,155,685...65,507,977
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
deguelin inhibits the reaction [TGFB1 protein affects the localization of SMAD4 protein]; deguelin inhibits the reaction [TGFB1 protein results in decreased expression of KRT18 protein]; deguelin inhibits the reaction [TGFB1 protein results in increased expression of CDH1 protein]; deguelin inhibits the reaction [TGFB1 protein results in increased expression of SNAI1 protein] |
CTD |
PMID:22986522 |
|
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
ISO |
deguelin results in increased expression of TIMP1 protein |
CTD |
PMID:25322282 |
|
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
increases expression |
ISO |
deguelin results in increased expression of TIMP2 protein |
CTD |
PMID:25322282 |
|
NCBI chr10:107,338,465...107,386,072
Ensembl chr10:107,338,465...107,386,072
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
deguelin inhibits the reaction [TNF protein affects the localization of and results in increased phosphorylation of RELA protein]; deguelin inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein]; deguelin inhibits the reaction [TNF protein results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; deguelin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]; deguelin inhibits the reaction [TNF protein results in increased expression of BCL2L1 mRNA]; deguelin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; deguelin inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; deguelin inhibits the reaction [TNF protein results in increased expression of CFLAR mRNA]; deguelin inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; deguelin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; deguelin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; deguelin inhibits the reaction [TNF protein results in increased expression of MUC mRNA]; deguelin inhibits the reaction [TNF protein results in increased expression of MYC protein]; deguelin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; deguelin inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; deguelin inhibits the reaction [TNF protein results in increased expression of TSLP mRNA]; deguelin inhibits the reaction [TNF protein results in increased phosphorylation of and affects the localization of RELA protein]; deguelin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; deguelin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:17015749 PMID:22623043 PMID:28529457 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression |
ISO |
[deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of TP53 protein; deguelin results in decreased expression of TP53 mRNA |
CTD |
PMID:22227970 PMID:25242579 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Tslp |
thymic stromal lymphopoietin |
multiple interactions |
ISO |
deguelin inhibits the reaction [TNF protein results in increased expression of TSLP mRNA] deguelin inhibits the reaction [OVAL protein results in increased expression of TSLP mRNA]; deguelin inhibits the reaction [OVAL protein results in increased expression of TSLP protein] |
CTD |
PMID:28529457 |
|
NCBI chr18:25,613,601...25,618,066
Ensembl chr18:25,613,831...25,617,361
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions decreases expression decreases response to substance |
ISO |
deguelin inhibits the reaction [IGF1 protein results in increased expression of VEGFA mRNA]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA protein] deguelin results in decreased expression of VEGFA protein VEGFA protein results in decreased susceptibility to deguelin |
CTD |
PMID:17764071 PMID:18575727 PMID:22623043 PMID:22745725 PMID:25322282 |
|
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
G |
Vim |
vimentin |
decreases expression |
ISO |
deguelin results in decreased expression of VIM protein |
CTD |
PMID:22986522 PMID:28509438 |
|
NCBI chr17:80,882,715...80,891,200
Ensembl chr17:80,882,666...80,891,212
|
|
G |
Wif1 |
Wnt inhibitory factor 1 |
increases expression |
ISO |
deguelin results in increased expression of WIF1 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 7:63,094,955...63,165,158
Ensembl chr 7:63,094,911...63,165,159
|
|
G |
Wnt10a |
Wnt family member 10A |
increases expression |
ISO |
deguelin results in increased expression of WNT10A mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 9:82,053,581...82,066,047
Ensembl chr 9:82,053,581...82,066,047
|
|
G |
Wnt11 |
Wnt family member 11 |
increases expression |
ISO |
deguelin results in increased expression of WNT11 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 1:163,794,136...163,813,756
Ensembl chr 1:163,797,660...163,813,756
|
|
G |
Wnt2 |
Wnt family member 2 |
increases expression |
ISO |
deguelin results in increased expression of WNT2 mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 4:45,286,845...45,332,899
Ensembl chr 4:45,292,437...45,332,420
|
|
G |
Wnt2b |
Wnt family member 2B |
decreases expression |
ISO |
deguelin results in decreased expression of WNT2B mRNA |
CTD |
PMID:19861542 |
|
NCBI chr 2:207,433,771...207,457,094
Ensembl chr 2:207,440,886...207,455,258
|
|
G |
Wnt3a |
Wnt family member 3A |
decreases expression |
ISO |
deguelin results in decreased expression of WNT3A mRNA |
CTD |
PMID:19861542 |
|
NCBI chr10:45,598,898...45,643,151
Ensembl chr10:45,598,912...45,638,035
|
|
G |
Wnt9a |
Wnt family member 9A |
decreases expression |
ISO |
deguelin results in decreased expression of WNT9A mRNA |
CTD |
PMID:19861542 |
|
NCBI chr10:45,659,045...45,686,103
Ensembl chr10:45,659,143...45,681,393
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression |
ISO |
deguelin results in decreased expression of XIAP protein |
CTD |
PMID:17035597 |
|
NCBI chr X:128,409,425...128,455,786
Ensembl chr X:128,409,472...128,453,000
|
|
|
G |
Acly |
ATP citrate lyase |
increases expression |
ISO |
osajin results in increased expression of ACLY mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
ISO |
osajin results in increased expression of AQP1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression |
ISO |
osajin results in increased expression of AQP3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245
|
|
G |
Ar |
androgen receptor |
decreases expression |
ISO |
osajin results in decreased expression of AR mRNA |
CTD |
PMID:20706672 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
increases expression |
ISO |
osajin results in increased expression of CD44 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cdh1 |
cadherin 1 |
increases expression |
ISO |
osajin results in increased expression of CDH1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
osajin results in increased expression of COL1A1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Cygb |
cytoglobin |
decreases expression |
ISO |
osajin results in decreased expression of CYGB mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:105,618,325...105,628,091
Ensembl chr10:105,618,326...105,628,091
|
|
G |
Dsg3 |
desmoglein 3 |
decreases expression |
ISO |
osajin results in decreased expression of DSG3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr18:15,652,948...15,688,605
Ensembl chr18:15,650,526...15,688,284
|
|
G |
Egf |
epidermal growth factor |
decreases expression |
ISO |
osajin results in decreased expression of EGF mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 2:68,820,616...68,895,537
|
|
G |
Esr2 |
estrogen receptor 2 |
decreases expression |
ISO |
osajin results in decreased expression of ESR2 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
increases expression |
ISO |
osajin results in increased expression of FGF1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
|
|
G |
Grn |
granulin precursor |
increases expression |
ISO |
osajin results in increased expression of GRN mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205
|
|
G |
Has1 |
hyaluronan synthase 1 |
decreases expression |
ISO |
osajin results in decreased expression of HAS1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 1:59,720,612...59,732,409
Ensembl chr 1:59,720,612...59,732,409
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
ISO |
osajin results in increased expression of HSPB1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr12:23,839,390...23,841,051
Ensembl chr12:23,839,399...23,841,049
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
ISO |
osajin results in decreased expression of IGF1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Il1a |
interleukin 1 alpha |
decreases expression |
ISO |
osajin results in decreased expression of IL1A mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Kl |
Klotho |
decreases expression |
ISO |
osajin results in decreased expression of KL mRNA |
CTD |
PMID:20706672 |
|
NCBI chr12:942,974...987,206
Ensembl chr12:943,006...987,551
|
|
G |
Krt5 |
keratin 5 |
increases expression |
ISO |
osajin results in increased expression of KRT5 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 7:143,320,142...143,324,536
Ensembl chr 7:143,316,920...143,453,546
|
|
G |
Mc1r |
melanocortin 1 receptor |
decreases expression |
ISO |
osajin results in decreased expression of MC1R mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:56,215,420...56,219,987
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
increases expression |
ISO |
osajin results in increased expression of COX1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression |
ISO |
osajin results in decreased expression of NOS2 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Nos3 |
nitric oxide synthase 3 |
increases expression |
ISO |
osajin results in increased expression of NOS3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Pgr |
progesterone receptor |
decreases expression |
ISO |
osajin results in decreased expression of PGR mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
|
|
G |
Plod3 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
increases expression |
ISO |
osajin results in increased expression of PLOD3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr12:22,716,421...22,726,982
Ensembl chr12:22,716,423...22,726,982
|
|
G |
Pomc |
proopiomelanocortin |
decreases expression |
ISO |
osajin results in decreased expression of POMC mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression |
ISO |
osajin results in decreased expression of PPARG mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ptger1 |
prostaglandin E receptor 1 |
decreases expression |
ISO |
osajin results in decreased expression of PTGER1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:24,799,422...24,803,373
Ensembl chr19:24,800,072...24,803,373
|
|
G |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
decreases expression |
ISO |
osajin results in decreased expression of RAD23A mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:25,949,488...25,956,677
Ensembl chr19:25,949,490...25,955,391
|
|
G |
Rara |
retinoic acid receptor, alpha |
increases expression |
ISO |
osajin results in increased expression of RARA mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:86,838,819...86,884,224
Ensembl chr10:86,860,685...86,884,210
|
|
G |
Rxra |
retinoid X receptor alpha |
decreases expression |
ISO |
osajin results in decreased expression of RXRA mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
|
|
G |
Sod3 |
superoxide dismutase 3 |
decreases expression |
ISO |
osajin results in decreased expression of SOD3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr14:60,958,583...60,971,143
Ensembl chr14:60,958,592...60,964,324
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases expression |
ISO |
osajin results in decreased expression of SRD5A2 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 6:25,279,635...25,315,501
Ensembl chr 6:25,279,626...25,315,511
|
|
G |
Tert |
telomerase reverse transcriptase |
decreases expression |
ISO |
osajin results in decreased expression of TERT mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
increases expression |
ISO |
osajin results in increased expression of TPT1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr15:57,891,680...57,894,504
Ensembl chr15:57,891,680...57,894,504
|
|
G |
Txn1 |
thioredoxin 1 |
increases expression |
ISO |
osajin results in increased expression of TXN mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
|
|
|
G |
Acly |
ATP citrate lyase |
increases expression |
ISO |
pomiferin results in increased expression of ACLY mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
ISO |
pomiferin results in increased expression of AQP1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression |
ISO |
pomiferin results in increased expression of AQP3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245
|
|
G |
Ar |
androgen receptor |
decreases expression |
ISO |
pomiferin results in decreased expression of AR mRNA |
CTD |
PMID:20706672 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
increases expression |
ISO |
pomiferin results in increased expression of CD44 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cdh1 |
cadherin 1 |
increases expression |
ISO |
pomiferin results in increased expression of CDH1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
pomiferin results in increased expression of COL1A1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Cygb |
cytoglobin |
decreases expression |
ISO |
pomiferin results in decreased expression of CYGB mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:105,618,325...105,628,091
Ensembl chr10:105,618,326...105,628,091
|
|
G |
Egf |
epidermal growth factor |
decreases expression |
ISO |
pomiferin results in decreased expression of EGF mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 2:68,820,616...68,895,537
|
|
G |
Esr2 |
estrogen receptor 2 |
decreases expression |
ISO |
pomiferin results in decreased expression of ESR2 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
ISO |
pomiferin results in decreased expression of FBN1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 3:117,569,708...117,766,160
Ensembl chr 3:117,569,697...117,766,120
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
increases expression |
ISO |
pomiferin results in increased expression of FGF1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
|
|
G |
Grn |
granulin precursor |
increases expression |
ISO |
pomiferin results in increased expression of GRN mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
ISO |
pomiferin results in increased expression of HSPB1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr12:23,839,390...23,841,051
Ensembl chr12:23,839,399...23,841,049
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
ISO |
pomiferin results in decreased expression of IGF1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Kl |
Klotho |
decreases expression |
ISO |
pomiferin results in decreased expression of KL mRNA |
CTD |
PMID:20706672 |
|
NCBI chr12:942,974...987,206
Ensembl chr12:943,006...987,551
|
|
G |
Krt5 |
keratin 5 |
increases expression |
ISO |
pomiferin results in increased expression of KRT5 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 7:143,320,142...143,324,536
Ensembl chr 7:143,316,920...143,453,546
|
|
G |
Mc1r |
melanocortin 1 receptor |
decreases expression |
ISO |
pomiferin results in decreased expression of MC1R mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:56,215,420...56,219,987
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
increases expression |
ISO |
pomiferin results in increased expression of COX1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Nos3 |
nitric oxide synthase 3 |
increases expression |
ISO |
pomiferin results in increased expression of NOS3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Pgr |
progesterone receptor |
decreases expression |
ISO |
pomiferin results in decreased expression of PGR mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
|
|
G |
Plod3 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
increases expression |
ISO |
pomiferin results in increased expression of PLOD3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr12:22,716,421...22,726,982
Ensembl chr12:22,716,423...22,726,982
|
|
G |
Pomc |
proopiomelanocortin |
decreases expression |
ISO |
pomiferin results in decreased expression of POMC mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression |
ISO |
pomiferin results in decreased expression of PPARG mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ptger1 |
prostaglandin E receptor 1 |
decreases expression |
ISO |
pomiferin results in decreased expression of PTGER1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:24,799,422...24,803,373
Ensembl chr19:24,800,072...24,803,373
|
|
G |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
decreases expression |
ISO |
pomiferin results in decreased expression of RAD23A mRNA |
CTD |
PMID:20706672 |
|
NCBI chr19:25,949,488...25,956,677
Ensembl chr19:25,949,490...25,955,391
|
|
G |
Rara |
retinoic acid receptor, alpha |
increases expression |
ISO |
pomiferin results in increased expression of RARA mRNA |
CTD |
PMID:20706672 |
|
NCBI chr10:86,838,819...86,884,224
Ensembl chr10:86,860,685...86,884,210
|
|
G |
Sod3 |
superoxide dismutase 3 |
decreases expression |
ISO |
pomiferin results in decreased expression of SOD3 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr14:60,958,583...60,971,143
Ensembl chr14:60,958,592...60,964,324
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases expression |
ISO |
pomiferin results in decreased expression of SRD5A2 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 6:25,279,635...25,315,501
Ensembl chr 6:25,279,626...25,315,511
|
|
G |
Tert |
telomerase reverse transcriptase |
decreases expression |
ISO |
pomiferin results in decreased expression of TERT mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
increases expression |
ISO |
pomiferin results in increased expression of TPT1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr15:57,891,680...57,894,504
Ensembl chr15:57,891,680...57,894,504
|
|
G |
Txn1 |
thioredoxin 1 |
increases expression |
ISO |
pomiferin results in increased expression of TXN mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
decreases expression |
ISO |
pomiferin results in decreased expression of TYRP1 mRNA |
CTD |
PMID:20706672 |
|
NCBI chr 5:98,387,291...98,406,083
Ensembl chr 5:98,387,291...98,406,083
|
|